CAI
Clinical Asset Index
by VOS Supply Group
Drugs · acquisition-cost intelligence

Clobetasol Propionate Cream 0.05% Clobetasol Propionate Cream 0.05%

clobetasol propionate· ingredient clobetasolCorticosteroids, plain· CLOBETASOL PROPIONATE .5 mg/g
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per GM
$0.15938
NADAC — pharmacy acquisition cost, not a retail/cash price

Acquisition-cost history

Weekly NADAC per GM — the trend nobody else shows. 7 weeks.

2025-12-172026-05-20

Same-ingredient options by acquisition cost

Other clobetasol products, cheapest acquisition cost first. Per GM — confirm strength/form equivalence before switching.

ProductNADAC / GMvs this
clobetasol propionate$0.11487−$0.04450
Clobetasol Propionate$0.12147−$0.03790
clobetasol propionate$0.17794+$0.01860
Clobex$0.24543+$0.08600
clobetasol propionate$0.32513+$0.16570
CLOBEX$0.33318+$0.17380
Clobex$0.34854+$0.18920
Clobetasol Propionate (emollient)$0.58990+$0.43050

Medicare Part D coverage · CY2026

On 311 plan formularies · typical tier 2
Prior auth 0% · Step therapy 0% · Quantity limit 66% of formularies

Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.